Efficacy of EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients harboring different types of EGFR mutations: A retrospective analysis
Crossref DOI link: https://doi.org/10.1007/s11596-017-1819-4
Published Online: 2017-12-21
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Hua-li
Han, Guang
Peng, Min
Weng, Yi-ming
Yuan, Jing-ping
Yang, Gui-fang
Yu, Jin-ming
Song, Qi-bin
Text and Data Mining valid from 2017-12-01
Article History
Received: 10 May 2017
Revised: 13 September 2017
First Online: 21 December 2017